A compound for use in the treatment of a disease amelio rated by the inhibition of Notum of formula (I) (2021)
Attributed to:
University College London - Equipment Account
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Type: Other
Volume: U.S. Patent Application No. 17/272,268